Effect of Aliskiren on Progression of Coronary Disease in Patients With Prehypertension: The AQUARIUS Randomized Clinical Trial
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: JAMA
Authors: Stephen J. Nicholls, George L. Bakris, John J. P. Kastelein, Venu Menon, Bryan Williams, Juergen Armbrecht, Patrick Brunel, Maria Nicolaides, Amy Hsu, Bo Hu, Hui Fang, Rishi Puri, Kiyoko Uno, Yu Kataoka, Dianna Bash, Steven E. Nissen
Institutions: South Australian Health and Medical Research Institute, University of Chicago, University of Chicago Medical Center, Amsterdam UMC Location University of Amsterdam, University of Amsterdam, Cleveland Clinic, National Institute for Health and Care Research, UCL Biomedical Research Centre, University College London, Novartis (Switzerland)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: aliskiren, renin inhibition, coronary artery disease, coronary artery disease progression, prehypertension, atheroma volume, intravascular ultrasound, renin-angiotensin-aldosterone system, atheroma regression, blood pressure reduction, cardiovascular risk factors, drug safety and tolerability, renin-angiotensin system
Open Access status: closed
OpenAlex ID: W2143360708
